Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biosense Webster leads the global market in electrophysiology devices for diagnosing/treating heart rhythm disorders. The company’s latest innovation—the VARIPULSE™ Platform—showed promising results in the admIRE study with a high rate of freedom from arrhythmia recurrence at one year post-ablation. No major adverse events were reported. The Laminar LAAX device for left atrial appendage elimination has entered a pivotal clinical trial comparing it to existing FDA-approved devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biosense Webster.